Skip to content

Safety and performance using SMILE with the VisuMax femtosecond laser system optimized for Presbyopia

Safety and performance using SMILE with the VisuMax femtosecond laser system optimized for Presbyopia - V2003CI

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028831
Enrollment
109
Registered
2023-06-16
Start date
2022-12-07
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA - 10038268 - Brechkraftstörung

Interventions

Group 1: Corneal refractive laser surgery using small incision lenticule extraction combined with micro-anisometropia using the VisuMax femtosecond laser system.

Sponsors

Carl Zeiss Meditec AG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: - Presence of myopia with or without astigmatism in both eyes with a need for laser set correction from -1.00 D up to -10.00 D sphere, cylinder up to 5.00 D, and spherical equivalent from -1.00 D up to -12.50 D - Patient age of 40 years or older - Presence of presbyopia - Preoperative CDVA of 20/25 or better in each eye - Ability and agreement to comply with follow-up visits and examinations

Exclusion criteria

Exclusion criteria: - Presence of at least one of the contraindications stated in the User Manual of the VisuMax option SMILE. This includes patients for whom lens extraction is the preferred alternative treatment. - Emmetropic refraction, defined as spherical equivalent refraction < -1.00 D in one or both eyes - Participation in other medical or pharmaceutical studies - Women during pregnancy and/or lactation or women who are planning to get pregnant - Patients whose freedom is impaired by administrative or legal order - Person is incapable of giving consent

Design outcomes

Primary

MeasureTime frame
Percentage of eyes with loss of 2 lines (10 letters) or more of corrected distance visual acuity at 3 months postoperative compared to the baseline visit

Secondary

MeasureTime frame
Percentage of eyes intended for emmetropia achieving uncorrected distance visual acuity of 20/40 or better at 3 months postoperatively

Countries

Austria, Czechia, Denmark, Germany, Poland, Switzerland

Contacts

Public ContactWalter Sekundo

Klinik für AugenheilkundeUniversitätsklinikum Gießen und MarburgGmbH, Standort Marburg

sekundo@med.uni-marburg.de+49 6421586 6275

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026